ENTITY
D.Western Therapeutics Institute Inc.

D.Western Therapeutics Institute Inc. (4576 JP)

31
Analysis
Health Care • Japan
D.Western Therapeutics Institute Inc.(DWTI) is a biotechnology (bio-venture) company that focuses on development of new drugs. The Company's focus is on protein kinase inhibitors. DWTI discovers and develops several drugs, such as antiglaucoma, antihypertensive, neuroprotective, antithrombogenic, antiatherosclerosis and anticancer.
more
Exchange Announcement • 13 Aug 2026 14:30

Consolidated Financial Results For The Six Months Ended June 30, 2026 (Based On Japanese Gaap)

Exchange Announcement • 13 Aug 2026 14:30

Q2 Fy12/26 Financial Results Briefing Materials

Exchange Announcement • 15 May 2026 14:30

Announcement Of Basic Agreement On U.S. Sales Partnership For "Bondlido"

Exchange Announcement • 14 May 2026 14:30

Consolidated Financial Results For The Three Months Ended March 31, 2026 (Based On Japanese Gaap)

Exchange Announcement • 19 Mar 2026 10:30

Announcement Regarding Completion Of The Observation Period For All Subjects In The Global Phase Iii Clinical Study Of K-321

x